Broad Spectrum Distillate
$1,250.00
-11%
CBD Isolate
$400.00
-15%
CBG Isolate
$1,800.00
-1%
Water Soluble CBD
$2,500.00
-8%
Back to news
7. May 2020
Cosmetics Global Market Watch News Production

Amyris Announces Major Breakthrough in CBD Skin Care Delivery

Amyris, Inc. (Nasdaq: AMRS), has presented clinical data showcasing the superiority of its natural sugarcane squalane as a carrier of CBD versus other oils.

In order for CBD to be effective in topical applications, skin penetration is a key factor. According to new research Amyris sugarcane squalene (marketed and sold as Neossance Squalane) can improve the efficacy of CBD skin penetration by a factor of 10-40 times when used as the carrier oil in skin care products.

The Cosmos Technical Center recently conducted a study to explore the skin penetration rate of CBD in Neossance Squalane versus jojoba oil, sunflower oil, MCT (medium-chain triglycerides), and hemp seed oil into human skin. The study measured the amount of CBD penetrated in a human epidermal skin model and found that Neossance Squalane delivered between 10-40 times more CBD to the epidermis than other carrier oils. The results also illustrated that CBD when used with Neossance Squalane penetrated skin faster, an important aspect for quicker and impactful skin relief.

Other oils tend to rest on the surface of the skin along with some of the CBD being carried, or clog skin pores without delivering a sufficient quantity of CBD as desired to the epidermis of the skin where it matters.

In addition to significantly improving the delivery of CBD, according to a review of top claims of CBD launched in 2019 from Mintel’s GNPD (Global New Products Database), Neossance Squalane helps brands meet 13 top claims consumers look for in CBD products such as moisturization, ethical sourcing, anti-aging, natural, and sustainable.

Amyris is developing CBD through fermentation technology and believes it will be the first company to provide highly pure and efficacious CBD from this technology at commercial scale. The ability to provide both high quality CBD and the best performing carrier chassis will provide consumers with greater choice and product effectiveness. The company has filed a patent application covering the use of squalane to deliver cannabinoids, including CBD, to the skin to protect its distinctive advantage.

We are very pleased with the breakthrough results from our clinical studies,” said Caroline Hadfield, President of Aprinnova. “This is a great example of how clean ingredients made from our science platform and naturally sourced from sugarcane combined with our scientific approach to formulations can lead to disruption in key markets. We are very excited to deliver what consumers are seeking and support the brands that are committed to delivering high efficacy and sustainability at an accessible value for consumers.

Source: PRNewswire